These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 8040114

  • 1. In-vitro evaluation of cefpodoxime.
    Valentini S, Coratza G, Rossolini GM, Massidda O, Satta G.
    J Antimicrob Chemother; 1994 Mar; 33(3):495-508. PubMed ID: 8040114
    [Abstract] [Full Text] [Related]

  • 2. [Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis].
    Wallrauch-Schwarz C, Milatovic D, Braveny I.
    Arzneimittelforschung; 1994 May; 44(5):668-70. PubMed ID: 8024645
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro activity of cefpodoxime in comparison with other oral beta-lactam antibiotics.
    Kayser FH.
    Infection; 1994 May; 22(5):370-5. PubMed ID: 7843823
    [Abstract] [Full Text] [Related]

  • 5. The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporins.
    Wise R, Andrews JM, Ashby JP, Thornber D.
    J Antimicrob Chemother; 1990 Apr; 25(4):541-50. PubMed ID: 2351624
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Activity of cefpodoxime against pathogens causing respiratory, urinary or soft tissue infections].
    Silva F, Durán C, Ulloa MT, Prado V.
    Rev Med Chil; 2005 Aug; 133(8):903-10. PubMed ID: 16163428
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Antibacterial activity of cefpodoxime against clinical isolates in 2000 and 2001].
    Abe T, Fukuoka T, Sato Y, Ito K, Sei M.
    Jpn J Antibiot; 2002 Dec; 55(6):827-43. PubMed ID: 12621736
    [Abstract] [Full Text] [Related]

  • 12. Antibacterial activity of cefpodoxime proxetil in a pharmacokinetic in-vitro model.
    Wiedemann B, Jansen A.
    J Antimicrob Chemother; 1990 Jul; 26(1):71-9. PubMed ID: 2211449
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T, Otsuki M, Hatano K, Nishihara Y.
    Chemotherapy; 1994 Jul; 40(3):167-82. PubMed ID: 8205935
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In-vitro activity of cefpodoxime against pathogens responsible for community-acquired respiratory tract infections.
    Dabernat H, Avril JL, Boussougant Y.
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():1-6. PubMed ID: 2127267
    [Abstract] [Full Text] [Related]

  • 20. [Antimicrobial activities of sulbactam/ampicillin against clinically isolated microbial strains].
    Deguchi K, Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Oda S, Tanaka S, Nakane Y, Fukumoto T.
    Jpn J Antibiot; 1995 Apr; 48(4):529-47. PubMed ID: 7783316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.